Skip to content

Clinical trials

Completed Phase 2 Pulmonary Disease, Chronic Obstructive trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Phase: Phase 2 Status: Completed Clear all

324 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20015
20023
20036
20049
200515
200617
200720
200834
200915
201028
201119
201217
201311
201415
201518
201610
201711
201813
20199
20204
20214
20227
20236
20245
20257

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed324

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline42
AstraZeneca37
Boehringer Ingelheim31
Chiesi Farmaceutici S.p.A.15
Novartis Pharmaceuticals10
Pearl Therapeutics, Inc.10
Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA9
Novartis8
Pfizer7
Dey6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive324
Emphysema35
Bronchitis, Chronic23
Asthma17
Lung Diseases12
Respiration Disorders11
Respiratory Aspiration9
Bronchiolitis Obliterans Syndrome8
Dyspnea7
Inflammation6

Trials

Showing 1 to 25 of 324. Each trial links to its page on Pharma Observatory.

224 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.